Stories tagged cervical cancer

Oct
14
2007

One million young girls to receive free vaccination

HPV vaccine, Gardasil
HPV vaccine, Gardasil
Merck & Co. announced that it will donate its cervical cancer vaccine, Gardasil, to inoculate 1 million women in some of the world's poorest countries. Poor nations account for 80 per cent of the 250,000 women killed by cervical cancer every year. Cervical cancer is caused by the Human Pappillioma Virus (HPV) a common sexually transmitted disease. Persistent infection with HPV is responsible for 99 percent of all cervical cancers.

Gardasil Access Program

The announcement was made at a conference organized by the UN Development Fund for Women in Brussels, Belgium and also at the Clinton Global Initiative conference in New York.

"In the near future, women around the world will not need to worry about themselves or their daughters, sisters, aunts, mothers and grandmothers succumbing to this disease,"
"Today I would like to add my voice to those demanding that cervical cancer gets the international political recognition it deserves. We are at the threshold of a new era for its prevention," said President Ellen Johnson Sirleaf of Liberia. unifem.org

The company said at least 3 million doses of Gardasil are to be distributed over the next five years. The vaccine is given in three shots, spread over six months.

Profit free protection for poor people

The Gardasil Access Program also exists to enable poor countries to vaccinate their people at dramatically lower prices (no profit for Merck). Partnerships with organizations like The Global Alliance for Vaccines and Immunization (GAVI), the World Health Organization (WHO), and Program for Appropriate Technology in Health (PATH), hopefully will mean that the world's poor will have an equal right to health.

Sources: New Scientist and Merck.com

Related Buzz article and discussion: Cervical cancer vaccine recommended for preteens

Jul
02
2007

Cervarix, a second vaccine for cervical cancer prevention.

Cervarix vaccine: competition for Gardasil
Cervarix vaccine: competition for Gardasil

Results of the new vaccine, Cervarix, were recently published in Lancet. Report co-author Dr Rachel Skinner said the results were very encouraging.

"We have found through this study that this vaccine is extremely effective in the prevention of pre-cancerous disease of the cervix due to infection with HPV types 16 and 18."
"However we now have evidence that Cervarix offers women broader protection by providing some protection against infections caused by HPV types 45 and 31. These types together with HPV types 16 and 18 account for 80 per cent of cases of cervical cancer worldwide.

Nearly 500,000 new cervical cancer victims each year.

Cervical cancer is a major global health problem, with nearly 500,000 new cases occurring each year worldwide. It is the second most common cancer - and the third leading cause of cancer deaths - in women worldwide. Each year an estimated 270,000 women die from the disease, and it is the leading cancer killer of women in the developing world.

Links to our ongoing discussions on cervical cancer vaccinations.

Source article: GlaxcoSmithKline

Gov. Rick Perry ordered Friday that schoolgirls in Texas must be vaccinated against the sexually transmitted virus that causes cervical cancer, making Texas the first state to require the shots. Breitbart.com